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This study investigated the use of previously superovulated ovaries as a source of oocytes, assessing the
competence of them for in vitro embryo production. Two superovulatory treatments were performed: equine
Chorionic Gonadotrophin (eCG) plus porcine Follicle-Stimulating Hormone (pFSH) in a single dose or the
conventional protocol of six decreasing doses of pFSH. Thirty donor ewes of the endangered Ojalada breed were
given either the simplified (group S; n15) or the decreasing-dose (group D; n15) treatments three times at
intervals of ]50 days. Ovaries were recovered on day 7 after the oestrus following the third treatment, just after
embryo flushing, and the oocytes were collected to assess in vitro maturation, fertilisation and development to the
blastocyst stage. The two superovulatory treatments did not differ in the mean number of oocytes selected for
maturation (7.191.2 and 8.591.5 per ewe in the D and S groups, respectively). The oocytes recovered from ewes
in Group D (87.5%) had a significantly (pB0.05) higher maturation rate than did those recovered from ewes in
group S (75%), but no differences were found in fertilisation rate (94% and 94.6% in the D and S groups,
respectively); both groups did not differ in their blastocyst rates and the total number of cells in in vitro-produced
blastocysts. In the two experimental groups, 1.7 (D) and 1.8 (S) in vitro-produced blastocysts were generated per
ewe, which indicate that it is feasible to combine in vivo and in vitro techniques to maximise embryo production in
endangered sheep breeds.
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1. Introduction
In vitro embryo production (IVEP) in sheep provides
an excellent source of low-cost embryos for basic
research in developmental biology and physiology. In
addition, IVEP might provide a means of improving
genetic gain by reducing the generation interval and
helping in the rescue of some endangered species or
breeds (Cognié et al. 2003; Mishra et al. 2010).
Currently, however, the efficiency of IVEP is lower
than that of in vivo embryo production, and collecting
embryos from a donor female is the most efficient
way to obtain high-quality embryos at a given stage
of development. In fact, and although no statistics on
current sheep embryo production are available, recent
data from the European Embryo Transfer Associa-
tion show that only 5.8% of bovine transferred
embryos were in vitro produced (Merton 2010; data
from 23 countries).
Ojalada Soriana is a Spanish breed of sheep of
which there are 8531 and 209 registered ewes and
rams, respectively; therefore, the Spanish government
considers the breed ‘in danger of extinction’ and
eligible to benefit from several programmes for the
production and cryoconservation of gametes and
embryos. Embryo banks seem to be the most
practical means of maintaining genetic diversity and
improving the genetic diversity of such local endan-
gered sheep genotypes that have few individuals but
are well adapted to specific breeding systems. How-
ever and in order to progressively transfer the
technology to the breeders associations, the in vivo
embryo production can be the first technology to be
implemented (Forcada et al. 2000).
A new means of maximising the number of
embryos recovered from a single donor ewe might
be to combine in vivo and in vitro embryo production,
which might be feasible for preservation of endan-
gered genotypes within a very small population and,
therefore, from a limited source of ewes as embryo
donors. In recent years, we have examined the effects
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of repeated superovulation for in vivo embryo pro-
duction in donor ewes at the end of their reproductive
lives as a means of increasing the progeny of these
valuable females (Forcada et al. 2000, 2006, Forcada
et al. 2011); however, we have not examined the
prospects of maximising embryo production from
ewes by combining in vitro and in vivo techniques.
Thus, the objective of our study was to investigate the
use of previously superovulated ovaries as a source
for oocyte production in mature Ojalada Soriana
ewes by assessing the effect of repeated (3) super-
ovulations on the number of oocytes recovered from
ovaries collected 7 days after oestrus following the
third superovulatory treatment, just after embryo
flushing. The competence of the oocytes for IVEP
was also assessed.
2. Materials and methods
The study was conducted between September 2008
and March 2009 at the experimental farm of the
University of Zaragoza, Spain (latitude 41840?N). All
procedures were approved by the in-house Ethics
Committee for Animal Experiments, University of
Zaragoza. The care and use of the animals adhered
to the Spanish Policy for Animal Protection
RD1201/05, which meets the requirements of the
European Union Directive 86/609 on the Protection
of Animals used for Experimental and Other Scien-
tific Purposes.
2.1. Animals
Thirty mature Ojalada Soriana ewes (6.790.5 year of
age and 5.290.4 previous lambings) from the Spanish
Association of Ojalada Soriana Breeders were
brought to the experimental farm, where they were
housed in communal yards that had uncovered areas
and fed a concentrate ration, lucerne hay and barley
straw at rates designed to provide 1.2 times their
maintenance requirements. Water was available at all
times.
2.2. Experimental design
Oestrus was synchronised using intravaginal sponges
that contained 30 mg fluorogestone acetate
(Sincropart†; Ceva Salud Animal S.A., Barcelona,
Spain), which were inserted for 14 d. Two super-
ovulatory protocols were performed: ewes in the
Simplified group (S; n15) received 250 IU of
pFSH (Folltropin†; Bioniche Animal Health, Du-
blin, Ireland) and 500 IU eCG (Sincropart†; Ceva
Salud Animal S.A.) in a single intramuscular (i.m.)
administration 48 h before the intravaginal sponge
was removed. Ewes in the Decreasing group (D;
n15) received 280 IU of pFSH in six i.m.
administrations that contained decreasing dosages
(2, 1.5 mL, 1.25 mL2 and 1 mL2) at 12-h
intervals, which began 48 h before the intravaginal
sponge was removed. Fertile rams were placed
with the ewes at the time of pessary withdrawal,
and ewes were examined for evidence of oestrus
every 8 h.
Embryos from superovulatory treatments were
collected through a mid-ventral laparotomy 7 days
after the onset of oestrus. For surgical procedures,
ewes were anesthetised using an i.m. administration
of 0.4 mL 2% xylazine and, 5 min later, an
intravenous (i.v.) injection of 10 mL sodium thiopen-
tal (20 mg/mL) (Thiobarbital, Braun Medical, Jaen,
Spain). Throughout the experiment (September
through March), the ewes were given the same
superovulatory treatment as many as three times at
intervals of at least 50 days.
2.3. Collection and in vitro maturation (IVM) of
oocytes
After embryos were collected following the third
superovulatory treatment, 7 days after oestrus, ewes
were euthanised using an i.v. injection of sodium
thiopental (T-61†; Intervet, Salamanca, Spain).
Ovaries were recovered and placed in Phosphate
Buffered Saline (PBS) supplemented with 100 IU/
mL of penicillin G and 100 mg/mL of streptomycin
sulphate and stored at 398C until they were
processed, not later than half an hour after
ovariectomy. Except where otherwise indicated, the
reagents were from Sigma-Aldrich Co., St Louis,
MO, USA. A combination of puncture and slicing
techniques (Wani et al. 1999) were used to collect
oocytes in a Petri dish that contained a handling
medium (Hepes-buffered TCM-199 supplemented
with 0.1% polyvinyl alcohol, 0.04% sodium bicar-
bonate, 25 IU/mL of heparin, 100 IU/mL of
penicillin G and 100 mg/mL of streptomycin sul-
phate). Following Wani et al. (2000), oocytes were
classified based on their cumulus cells and cyto-
plasm morphology, and only the oocytes that had
several layers of cumulus cells and a uniform
cytoplasm (healthy oocytes) were selected for
IVM. Oocytes were transferred into a maturation
medium that contained bicarbonate-buffered TCM-
199 supplemented with 10% (v/v) oestrous sheep
serum, 0.1 mg/mL each of FSH and Luteinizing
Hormone (LH), 100 mM of cysteamine, 0.3 mM of
sodium pyruvate, 100 IU/mL of penicillin G and
100 mg/mL of streptomycin sulphate, which was
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covered with mineral oil and incubated at 398C
under 5% CO2 and saturated humidity for 24 h.
2.4. In vitro fertilisation and embryo culture
At the end of IVM, the oocytes were denuded from
the cumulus cells and transferred to the fertilisation
medium, which consisted of synthetic oviductal fluid
(SOF) without glucose (Tervit and Whittingham
1972) and was supplemented with 2% (v:v) of
oestrous sheep serum, 10 mg/mL of heparin and 1
mg/mL of hypotaurine. On the same day of fertilisa-
tion, the semen collected from four Ojalada rams was
pooled, diluted 1:10 in a saline medium that con-
tained 0.25 mol/L of sucrose, 10 mmol/L of Hepes, 2
mmol/L of potassium hydroxide, 5 mmol/L of
glucose, 0.5 mol/L of sodium phosphate monobasic
and 100 mmol/L of ethylene glycol tetra-acetic acid,
and kept at 158C until fertilisation. Highly motile
spermatozoa were selected based on the swim-up
technique (Wani et al. 2000; Luther et al. 2005),
added to the fertilisation medium that contained the
oocytes at a final concentration of 1106 sperma-
tozoa/mL, which was covered with mineral oil and
incubated for 24 h at 398C in an atmosphere of 5%
CO2. At 24 and 36 h after fertilisation, cleaved
embryos were placed in a culture medium that
contained SOF supplemented with essential and
non-essential amino acids at oviductal concentrations
(Walker et al. 1996), 0.4% bovine serum albumin (wt/
vol), 1 mM of l-glutamine, 100 IU/mL of penicillin G
and 100 mg/mL of streptomycin sulphate, and covered
with mineral oil and kept at 398C in a maximally
humidified atmosphere of 5% CO2, 5% O2 and 90%
N2 for 8 days until the blastocyst stage.
2.5. Peroxide status evaluation
High intracellular concentrations of hydrogen perox-
ide in blastocysts can cause cellular damage and
apoptosis (Yang et al. 1998; Sakatani et al. 2008). The
concentrations of peroxides in hatched in vitro-
produced embryos (n8 and n7 from ewes in the
D and S groups, respectively) were quantified on day
8 after fertilisation using dichlorodihydrofluorescein
diacetate (DCHFDA) (after Hashimoto et al. 2000).
Blastocysts were transferred to a culture medium that
contained 10 mM DCHFDA and, after 20 min, the
embryo nuclei were counterstained using HOECHST
33342 (10 mg/mL) for 10 min. Embryos were fixed
using 1.5% of glutaraldehyde for 15 min, washed in
PBS and then mounted on glass slides using CC/
mount† mounting medium. The fluorescent emis-
sions from the embryos were recorded under a
fluorescent microscope equipped with Fluorescein
Isothiocyanate (FITC) filters (excitation, 405435
nm; emission, 515 nm). To minimise subjective
observation errors, the coded samples were evaluated
by a blinded operator. A bright green fluorescence
indicated that a cell was DCHFDA-positive, and the
HOECHST stain facilitated the counting of cells.
2.6. Statistical analysis
The following information was recorded for each
animal in both experimental groups: number of
oocytes recovered, number of healthy oocytes selected
for maturation and number of non-healthy oocytes.
All of them were expressed as mean9SEM. The
numbers of matured oocytes, fertilised embryos,
cleaved embryos and blastocysts were expressed as
totals for each group. Maturation and cleavage rates
were calculated over the number of healthy oocytes,
fertilisation rate was based on the number of matured
oocytes, and blastocyst rates were based on the
number of cleaved embryos. The significance of
differences in maturation, fertilisation, cleavage and
blastocyst rates were evaluated statistically using Chi-
square tests. Differences among the two experimental
groups in the number of oocytes selected for matura-
tion, total number of cells and the number of cells
that were DCHFDA-positive (i.e., higher hydrogen
peroxide concentrations) per blastocyst were com-
pared using a one-way ANOVA. Within each super-
ovulatory treatment, the relationship between in vivo
embryo production and the number of oocytes
recovered per ewe was analysed using a correlation
matrix. The probability level for statistical signifi-
cance was set to pB0.05.
3. Results
The number of oocytes recovered per ewe and
selected for maturation from previously superovu-
lated Ojalada Soriana ewes did not differ significantly
between the D (7.191.2) and the S treatments
(8.591.5). In both groups, the mean numbers of
non-selected oocytes were 4.190.7 and 5.190.9,
respectively. In the D group, neither the total number
of oocytes recovered nor the number of oocytes
selected per ewe was significantly correlated with in
vivo embryo production parameters (ovulation rate,
numbers of ova and embryos recovered and the
number of viable or freezable embryos) in the first
recovery or in the three consecutive recoveries
combined (Table 1). In the S group, however, oocyte
production was negatively correlated with the total
number of viable and freezable embryos produced
after the three consecutive recoveries, which indicated
that high embryo production, in response to repeated
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applications of a single dose of eCGFSH, can
impair oocyte yield and quality from these super-
ovulated ovaries.
In the early stages of the IVEP procedure, the
oocytes recovered from the ewes that received the
pFSH treatment (D group) seemed to have a higher
competence (significantly higher maturation and
cleavage rates) than did those recovered from ewes
that received the eCGFSH treatment (S group)
(Table 2). However, both experimental groups did
not differ significantly in blastocyst rates (Table 2)
or in the development during embryo culture when
data were analysed by culture day and blastocyst
type (Table 3).
Superovulatory treatments did not differ signifi-
cantly in the mean number of cells (HOECHST
staining) (160924 and 188928 cells in the D and S
groups, respectively), and the number of cells that
were DCHFDA-positive (higher hydrogen peroxide
concentrations) per embryo (13.793.5 and
19.194.1 cells in the D and S groups, respectively).
4. Discussion
In the present study, the production and quality of
oocytes from previously superovulated ovaries that
were subjected to three consecutive superovulatory
treatments were similar in the two superovulatory
experimental groups (11.2 and 13.7 oocytes recovered
per ewe with a 63% and 62% of selected oocytes in
group D and S, respectively). Recently, Vázquez et al.
(2010) have reported recovery of 16.1 oocytes and a
60% of selected oocytes after a commercial treatment
with 400 IU of eCG also during the seasonal
anoestrus. Concerning ovum pick-up recovery
through laparotomy or laparoscopy, the mean num-
ber of selected oocytes per ewe varied between 3.1 and
10.0 among ewes subjected to different FSH super-
ovulatory regimes (Baldassarre et al. 1996 in Mer-
inoCorriedale; Ptak et al. 1999 in Sarda; Alberio
et al. 2002 and Hammami 2008 in Rasa Aragonesa;
Veiga-López et al. 2008 in Manchega).
The weak, but statistically significant negative
correlation between oocyte production and in vivo
embryo recovery after three consecutive treatments
among Ojalada Soriana ewes in the S group was
unexpected. It is possible that mature, previously
superovulated Ojalada Soriana ewes respond to
repeated administrations of a single dose of
pFSHeCG for superovulation by creating anti-
eCG antibodies (Forcada et al. 2011). In those
ewes, plasma anti-eCG antibody concentrations in-
creased from day 5 after eGC administration (Roy
et al. 1999). In general, high levels of anti-eCG
antibodies are associated with alterations of follicular
dynamics, especially, delays in follicular growth (Roy
et al. 1999) and, therefore, with alterations in the
corresponding follicular wave. Given that in vivo
embryo production after three consecutive super-
ovulatory treatments was very similar in the two
treatment groups, the relationship between high
embryo production and the impairment of oocyte
yield and quality among ewes that received repeated
administrations of the simplified treatment might
reflect the negative effects of high concentrations of
anti-eCG plasma antibodies.
Oocytes recovered from superovulated ovaries can
have impaired maturation rates (Berlinguer et al.
Table 1. Pearson correlation coefficients between the
number of oocytes recovered post-mortem (R) or the
number of oocytes selected for in vitro maturation (M)
per ewe and parameters associated with in vivo embryo
production from Ojalada Soriana ewes treated with either
210 IU of pFSH plus 500 IU of eCG administered as a
single dose (S) or 280 IU of pFSH administered in six
incrementally decreasing doses (D). The in vivo embryo
production data were from the first (F) or the combined
totals (T) of three consecutive embryo recoveries.
Groups
D S
Parameters M R M R
Ovulation rate F 0.03 0.03 0.09 0.23
Ovulation rate T 0.08 0.12 0.12 0.12
Recovered ova and
embryos F
0.15 0.10 0.23 0.29
Recovered ova and
embryos T
0.15 0.12 0.06 0.11
Viable embryos F 0.20 0.14 0.15 0.12
Viable embryos T 0.01 0.30 0.46** 0.46**
Freezable embryos F 0.24 0.16 0.16 0.14
Freezable embryos T 0.02 0.10 0.40* 0.38*
*pB0.1; **pB0.05.
Table 2. In vitro maturation, fertilisation, cleavage and blastocyst rates for oocytes recovered post-mortem from Ojalada
Soriana ewes that had previously received three consecutive superovulatory treatments for in vivo embryo production. The
superovulatory treatments were either 210 IU of pFSH plus 500 IU of eCG administered as a single (S) or 280 IU of pFSH
administered in six incrementally decreasing doses (D).
Group Maturation Fertilisation Cleavage Blastocyst rate
D 84/96 (87.5%)a 79/84 (94%)a 79/96 (82.3%)a 25/79 (31.6%)a
S 93/124 (75%)b 88/93 (94.6%)a 87/124 (70.2%)b 27/87 (27%)a
Note: Within columns, different letters (a, b) indicate differences at p B0.05.
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2004; Hammami 2008), particularly, after ‘decreas-
ing-dose’ FSH protocols, in which the first high doses
can induce rapid, abnormal follicular development
and asynchrony between growing follicles and folli-
cular status (Blondin et al. 1996), because a plateau
phase (Sirard et al. 1999) is necessary to complete
oocyte capacitation (Hyttel et al. 1997). In our
experiment, oocytes were not recovered in the oestrus
induced by the superovulatory treatments, but in the
subsequent follicular wave. The maturation and
cleavage rates exhibited by the oocytes recovered
from ovaries of ewes superovulated using the simpli-
fied protocol were lower than the rates of the oocytes
recovered from ovaries subjected to the decreasing-
doses protocol; the high anti-eCG antibody concen-
trations in some of the ewes in the S group (Forcada
et al. 2011) might have contributed to the difference
in oocyte competence. In our experiment, blastocyst
rates did not differ significantly between treatment
groups. Thus, the in vitro culture of embryos did not
indicate a negative effect of previous treatments with
eCG on oocyte competence. In ewe lambs, Kelly et al.
(2005) reported that oocytes following a pFSH-based
superovulatory treatment that included eCG that
were matured and fertilised in vitro, had higher
blastocyst rates than did the oocytes recovered after
a treatment without eCG (Kelly et al. 2005).
Embryos produced in vivo following a simplified
pFSHeCG superovulatory treatment can have few-
er cells and, therefore, lower viability and tolerance to
cryopreservation than do embryos derived from
treatments based on repeated doses of pFSH (Leoni
et al. 2001; Forcada et al. 2011). In our study, the
numbers of total and DCHFDA-positive cells in
blastocysts from in vitro-produced oocytes did not
differ significantly between the two superovulatory
treatment groups which suggests that the negative
effect of the simplified protocol on embryo quality is
not apparent in the follicular wave that follows the
oestrus induced by the superovulatory treatment.
However, the technical and commercial viability of
the pFSHeCG protocol require further study.
In conclusion, our study demonstrates that, in the
early stages of IVEP, the competence of the oocytes
recovered at day 7 after oestrus, just after embryo
flushing, from mature, previously superovulated
Ojalada Soriana ewes was lower in those treated
with a single dose of eCG plus pFSH than it was in
ewes treated with the standard pFSH treatment.
Those differences disappeared after fertilisation, and
blastocyst rates and the viability of blastocysts did
not differ among experimental groups. A total of 25
and 27 in vitro-produced blastocysts were generated
in the decreasing and simplified groups, correspond-
ing to 1.7 and 1.8 blastocysts per ewe, respectively.
Considering that the total number of in vivo-produced
embryos per ewe that received the three superovula-
tory treatments was 14.1 (D group) and 13.7 (S
group), the numbers of in vivo- and in vitro-produced
embryos per donor ewe were 15.8 (D group) and 15.5
(S group), which indicates that, although the in vitro
procedures are less efficient, the combination of both
techniques could be useful to maximise embryo
production in endangered sheep genotypes.
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Cognié Y, Baril G, Poulin N, Mermillod P. 2003. Current
status of embryo technologies in sheep and goat.
Theriogenology 59:171188.
Forcada F, Abecia JA, Cebrian-Perez JA, Muino-Blanco T,
Valares JA, Palacin I, Casao A. 2006. The effect of
melatonin implants during the seasonal anestrus on
embryo production after superovulation in aged high-
prolificacy Rasa Aragonesa ewes. Theriogenology
65:356365.
Forcada F, Ait Amer-Meziane M, Abecia JA, Maurel MC,
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